Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and diseased conditions including cancer. Indeed, breast cancer-associated stromal cells not only increase the quantity of deposited Fn but also modify its conformation. However, (i) the interplay between mechanical and conformational properties of early tumor-associated Fn networks and (ii) its effect on tumor vascularization remain unclear. Here, we first used the Surface Forces Apparatus to reveal that 3T3-L1 preadipocytes exposed to tumor-secreted factors generate a stiffer Fn matrix relative to control cells. We then show that this early matrix stiffening correlates with increased molecular unfolding in Fn fibers, as determined by Förster Reson...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Predicting which benign and early stage breast lesions will transform is a major therapeutic challen...
AbstractFibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological...
Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and dis...
Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and dis...
The extracellular matrix (ECM) is a complex fibrillar structure that provides biochemical and mechan...
Background Changes in fibronectin (Fn) matrix remodeling contribute to mammary tumor angiogenesis an...
Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ...
Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ...
Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffen...
Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffen...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Predicting which benign and early stage breast lesions will transform is a major therapeutic challen...
AbstractFibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological...
Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and dis...
Fibronectin (Fn) forms a fibrillar network that controls cell behavior in both physiological and dis...
The extracellular matrix (ECM) is a complex fibrillar structure that provides biochemical and mechan...
Background Changes in fibronectin (Fn) matrix remodeling contribute to mammary tumor angiogenesis an...
Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ...
Tumors are characterized by extracellular matrix (ECM) remodeling and stiffening. The importance of ...
Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffen...
Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffen...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Tumors are characterized by extracellular matrix (ECM) deposition, remodeling, and cross-linking tha...
Predicting which benign and early stage breast lesions will transform is a major therapeutic challen...